GRC
富华资本
GRC is a venture capital fund that co-led the Pre-A round of Bioyen Biotech (柏垠生物), a synthetic-biology-based biomaterials startup founded in March 2021 by CAS Shenzhen Institute of Advanced Technology researcher Dr. Zhong Chao and his university classmate Cui Junfeng . In January 2023, GRC joined Yunqi Capital and Fuhua Capital to lead the over-100-million-yuan round, with Cornerstone Capital and Yayi Capital following on . The fund is also referred to as 富华资本 in Chinese sources .
AI-generated — may contain errors, please verify.
Coverage
二月，回归对世界的想象力 | 5Y News Monthly
上个月发生的大事儿。
五源资本·5Y News | Portfolio Company PAM2L Biotechnologies Closes Pre-A Round of Over 100 Million RMB
Leveraging synthetic biology and machine learning as dual engines to drive bio-based materials and product development.
五源资本·"Bioyen Bio" Closes Over 100 Million Yuan Pre-A Round, Led by Yunqi Capital | Yunqi Capital
Leading research in materials synthetic biology, building an efficient innovation R&D platform
云启资本·
